1. Home
  2. FGI vs CERO Comparison

FGI vs CERO Comparison

Compare FGI & CERO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FGI
  • CERO
  • Stock Information
  • Founded
  • FGI 1987
  • CERO 2017
  • Country
  • FGI United States
  • CERO United States
  • Employees
  • FGI N/A
  • CERO N/A
  • Industry
  • FGI Industrial Specialties
  • CERO
  • Sector
  • FGI Industrials
  • CERO
  • Exchange
  • FGI Nasdaq
  • CERO Nasdaq
  • Market Cap
  • FGI 8.0M
  • CERO 8.4M
  • IPO Year
  • FGI 2022
  • CERO N/A
  • Fundamental
  • Price
  • FGI $0.87
  • CERO $1.92
  • Analyst Decision
  • FGI
  • CERO
  • Analyst Count
  • FGI 0
  • CERO 0
  • Target Price
  • FGI N/A
  • CERO N/A
  • AVG Volume (30 Days)
  • FGI 6.0K
  • CERO 787.1K
  • Earning Date
  • FGI 03-19-2025
  • CERO 02-20-2025
  • Dividend Yield
  • FGI N/A
  • CERO N/A
  • EPS Growth
  • FGI N/A
  • CERO N/A
  • EPS
  • FGI N/A
  • CERO N/A
  • Revenue
  • FGI $127,180,460.00
  • CERO N/A
  • Revenue This Year
  • FGI $11.39
  • CERO N/A
  • Revenue Next Year
  • FGI $6.26
  • CERO N/A
  • P/E Ratio
  • FGI N/A
  • CERO N/A
  • Revenue Growth
  • FGI 7.71
  • CERO N/A
  • 52 Week Low
  • FGI $0.70
  • CERO $1.76
  • 52 Week High
  • FGI $1.85
  • CERO $1,238.00
  • Technical
  • Relative Strength Index (RSI)
  • FGI 55.71
  • CERO 34.43
  • Support Level
  • FGI $0.86
  • CERO $1.76
  • Resistance Level
  • FGI $0.90
  • CERO $3.18
  • Average True Range (ATR)
  • FGI 0.03
  • CERO 0.38
  • MACD
  • FGI 0.00
  • CERO 0.30
  • Stochastic Oscillator
  • FGI 66.67
  • CERO 19.72

About FGI FGI Industries Ltd.

FGI Industries Ltd is a supplier of kitchen and bath products. It offers sanitaryware, bath furniture, shower systems, customer kitchen cabinetry, and other accessory items. It is business to business supplier of bath and kitchen products to large retail, wholesale, commercial, and specialty channel customers around the globe. its revenue is generated by sanitaryware. Geographically it operates in the United States, Canada, Europe, Rest of the World, and the majority of its revenue comes from the United States.

About CERO CERo Therapeutics Holdings Inc. Common Stock

CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T-cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy.

Share on Social Networks: